FMOPhore for hotspot identification and efficient fragment-to-lead growth strategies

01 October 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Fragment based drug design (FBDD) is like a chess game in that a good or a bad move can dramatically influence the outcome. At the start of the design process, it is important to identify the key binding site residues (hotspots) that can have a substantial impact on ligand efficiency (LE) and binding. Here, we introduce a novel, fully automated algorithm named FMOPhore, which performs Quantum Mechanics Fragment Molecular Orbital (QM-FMO) calculations on 3D-protein-ligand pharmacophore models. This is implemented in a novel scoring function named FP-score to classify binding site residues in two classes: 1) Hotspot residues (further delineated into three categories; Anchor, Transient, and Accessible) and 2) Non-hotspot residues. We apply our algorithm in two different scenarios: holo-complex and apo-structure scenarios, testing its robustness on sixteen different protein targets including the application for fragment growing and target selectivity. We demonstrate that handling protein binding site flexibility using Dy-FMOPhore improves hotspots detection. The FMOPhore algorithm can be a powerful tool in identifying and quantifying binding site hotspots to enable an efficient design strategy for fragment-to-lead optimization.

Keywords

Fragment based drug design
Hotspots
pharmacophore model
Quantum Mechanics Fragment Molecular Orbital (QM-FMO)
fragment-to-lead growing strategies
FP-score

Supplementary materials

Title
Description
Actions
Title
FMOPhore Supplementary files
Description
FMOPhore 2D and 3D models on all systems mentioned in the paper.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.